Evidence-based peptide research, plainly read
We aggregate and interpret peer-reviewed peptide literature — and we tell you how much weight each claim can carry.
Peptide science moves fast and gets distorted faster. Residua exists to sit between the primary literature and the reader: gathering peer-reviewed work, summarising it honestly, and grading the strength of the evidence behind every claim.
We are an editorial review, not a laboratory, a clinic, or a vendor. We sell nothing and recommend no products.
How we work
Source-first
Every summary links to original literature on PubMed, Nature, ScienceDirect, NIH/NCBI or ClinicalTrials.gov — not to secondary blogs.
Evidence-graded
A visible badge marks each piece from Meta-analysis to Preprint / Emerging, so the level of confidence is never hidden.
Opinion, sequestered
Editorials are labelled and filed apart from research summaries. Argument is welcome; it just never wears the lab coat.
Correctable
We publish with references so readers can check us, and we revise when the evidence does.
Educational use only — not medical advice
Residua is published for general educational and informational purposes about peptide research. Nothing on this site is medical, clinical, diagnostic, or treatment advice, and reading it does not create a clinician–patient relationship.
Many peptides discussed are investigational, and some are not approved as therapeutics in any jurisdiction. Legal status, safety, and appropriate use vary by country and by individual. Do not start, stop, or change any treatment based on this site.
Always consult a qualified, licensed healthcare professional before acting on any information related to peptides or your health.